IBRX is trading at $8.59, up 10.2% versus the comparison close of $7.79 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 IBRX makes sharp 10.2% jump
Immunitybio Inc
Related News
IBRX
ImmunityBio Reports 71% Complete Response Rate in Bladder Cancer Trial
IBRX
🔴 Immunitybio is trading 5% down today amid biotech sector weakness
IBRX
🟢 Immunitybio is trading 5.65% up today after FDA expanded ANKTIVA approval for bladder cancer treatment
IBRX
IBRX Receives Expanded FDA Approval for ANKTIVA in Bladder Cancer Treatment
IBRX